Stockscreener 앱 받기
1.68
1.75%
-0.03
시간 외 거래:
1.69
0.01
+0.60%
전일 마감가:
$1.71
열려 있는:
$1.65
하루 거래량:
6.90M
Relative Volume:
1.00
시가총액:
$544.56M
수익:
-
순이익/손실:
$-283.26M
주가수익비율:
-1.1429
EPS:
-1.47
순현금흐름:
$-273.61M
1주 성능:
-30.58%
1개월 성능:
-35.63%
6개월 성능:
-59.62%
1년 성능:
-83.20%
1일 변동 폭
$1.54
$1.7571
1주일 범위
$1.54
$2.398
52주 변동 폭
$1.52
$10.50
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.68 | 544.56M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana ... - Bluefield Daily Telegraph
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc. (SANA) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
The Gross Law Firm Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSANA - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact Levi & Korsinsky about pending Class ActionSANA - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - PR Newswire
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Bank of New York Mellon Corp Acquires 9,905 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Seattle biotech firm faces investor lawsuit over alleged misleading statements - The Business Journals
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA - GlobeNewswire
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action ... - Eagle-Tribune
Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP Before May 20, 2025 to Discuss Your Rights – SANA - MSN
Shareholders that lost money on Sana Biotechnology, Inc. - GlobeNewswire
No Stopping Sana Biotechnology Inc (NASDAQ: SANA)’s Stock Plunged? - Stocks Register
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 - Seeking Alpha
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire
Seattle Biotech Duped Investors On Drug Progress, Suit Says - Law360
Investor Alert: Robbins LLP Informs Investors of the Sana Biotechnology, Inc. Class Action Lawsuit - The Eastern Progress Online
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Sana Investor Says It Hid Low Cash Before Record Stock Selloff - Bloomberg Tax
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Sana Biotechnology, Inc. (SANA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - TradingView
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sana Biotechnology, Inc. (SANA) - TradingView
Research Analysts Set Expectations for SANA Q1 Earnings - Defense World
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift - Investing.com
Sana Biotechnology’s (SANA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sana Biotechnology (NASDAQ:SANA) Upgraded to Outperform at Citizens Jmp - Defense World
Sana Biotechnology Faces Uncertainty as Financial Struggles Threaten Future Operations - TipRanks
Sana Biotechnology (NASDAQ:SANA) Sees Unusually-High Trading Volume After Strong Earnings - Defense World
Citizens Capital Markets Upgrades Sana Biotechnology (SANA) - Nasdaq
Sana Biotechnology stock upgraded at Citizens (SANA:NASDAQ) - Seeking Alpha
Sana Biotechnology upgraded at Citizens on valuation - MSN
Sana stock holds $11 target post-positive trial update By Investing.com - Investing.com Canada
Sana Biotech stock rating upgraded to Market Outperform By Investing.com - Investing.com UK
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.05%
1.79%
자본화:
|
볼륨(24시간):